Tag: partnerships

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

Key Highlights:

The Asia-Pacific space power supply market, valued at $981.89 million in 2024, is set to grow at a CAGR of 4.99%, reaching $1.59 billion by 2034. Key drivers include rising regional launch activities from China's Tianwen and India's Gaganyaan, and ASEAN small-sat constellations, alongside a growing demand for portable, dependable power solutions. Innovations such as AI-enabled MPPT controllers and Li-ion batteries reduce mass and boost durability. Major players like SHARP CORPORATION and Mitsubishi Electric lead a competitive landscape, bolstered by regional partnerships and investments in sustainable, cost-efficient technologies.